StonvexLoading…
StonvexStonvexStonvexCore line items from RMR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $182.70M | $193.92M | $236.16M | $199.98M |
Operating Income | $41.78M | $44.98M | $113.73M | $88.37M |
Net Income | $17.60M | $23.13M | $57.15M | $34.00M |
EPS (Diluted) | $1.03 | $1.38 | $3.44 | $2.04 |
Total Assets | $718.25M | $700.49M | $582.42M | $542.40M |
Total Liabilities | $316.23M | $281.08M | $158.76M | $172.67M |
Cash & Equivalents | $62.30M | $141.60M | $267.99M | $189.09M |
Free Cash Flow OCF − CapEx | Not available | $57.51M | $105.23M | $100.15M |
Shares Outstanding | 16.64M | 15.00M | 15.00M | 15.00M |